CN103656542A - Drug for treating erythroderma desquamativum and preparation method thereof - Google Patents

Drug for treating erythroderma desquamativum and preparation method thereof Download PDF

Info

Publication number
CN103656542A
CN103656542A CN201210323561.6A CN201210323561A CN103656542A CN 103656542 A CN103656542 A CN 103656542A CN 201210323561 A CN201210323561 A CN 201210323561A CN 103656542 A CN103656542 A CN 103656542A
Authority
CN
China
Prior art keywords
radix
rhizoma
medicine
parts
erythroderma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210323561.6A
Other languages
Chinese (zh)
Inventor
杨波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210323561.6A priority Critical patent/CN103656542A/en
Publication of CN103656542A publication Critical patent/CN103656542A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a drug for treating erythroderma desquamativum and a preparation method thereof. The drug aims to solve the problem in the prior art that the erythroderma desquamativum is treated by hormone to bring large side effects to patients while the erythroderma desquamativum treating is performed. The drug is prepared from the following raw materials in parts by weight: 5-10 parts of coptis, 6-8 parts of henry hemsleya root, 3-5 parts of hemsleya macrosperma, 3-5 parts of blackberry lily, 5-10 parts of ginger, 3-5 parts of onion and 20-200 parts of cactus. The drug disclosed by the invention can improve immunity of human body so as to treat the erythroderma desquamativum by autoimmunity of the human body. The drug adopts traditional Chinese medicine components, thereby being free of toxic side effect, good in curative effect and capable of effectively shortening the treatment cycle, reducing the treatment cost and reducing the economic burden of patients.

Description

A kind of medicine for the treatment of erythroderma desquamativum and preparation method thereof
Technical field
The present invention relates to field of medicaments, especially a kind of medicine for the treatment of erythroderma desquamativum and preparation method thereof.
Background technology
Erythroderma is a kind of serious systemic disease, and its principal character is that extensive and obvious erythema infiltrates infringement with pityrosporum shape desquamation, and skin involvement area is greater than more than 90% conventionally.According to data, adult's erythroderma accounts for 0.3% of department of dermatologry patient sum, take male as main, is mainly in 45 years old above person.According to the difference of the factor of curing the disease, cocoa is summarized as 4 classes: (1) is secondary to the erythroderma that other dermatosiss cause; ; (2) erythroderma that external or systemic administration cause; (3) erythroderma causing due to malignant tumor; (4) other factors, such as after hepatitis, radiotherapy, after shell operation companion blood transfusion etc., the erythroderma causing.Wherein, erythroderma desquamativum is a kind of comparatively common erythroderma.
At present, treatment erythroderma desquamativum mainly adopts hormone to treat.It,, in treatment erythroderma, brings great side effect to patient, causes weight in patients increase etc., has a strong impact on the orthobiosis after patient cures.
Summary of the invention
Goal of the invention of the present invention is: for prior art, adopt hormone therapy erythroderma desquamativum, in treatment erythroderma, to patient, bring the problem of great side effect, a kind of medicine for the treatment of erythroderma desquamativum is provided, it prevents that by medicine erythroderma from infecting, can improve body immunity, by human body autoimmune, reach the object for the treatment of erythroderma desquamativum simultaneously.This medicine adopts Chinese medicine ingredients, has no side effect, and therapeutic effect is good, can effectively shorten treatment cycle, reduces treatment cost, alleviates patient's economy and body burden.
The technical solution used in the present invention is as follows:
Treat a medicine for erythroderma desquamativum, adopt and comprise that the raw material of following weight portion is prepared from: 5-10 part Rhizoma Coptidis, 6-8 part Neoalsomitra integrifoliola (Cogn.) Hucth., 3-5 part Radix Hemsleyae Macrospermae, 3-5 part Rhizoma Belamcandae, 5-10 part Rhizoma Zingiberis Recens, 3-5 part Herba Alii fistulosi, 20-200 part Radix et Caulis Opuntiae Dillenii.
The raw material that also comprises following weight portion: 5-10 part Radix Angelicae Sinensis, 3-5 part Rhizoma Polygonati Odorati, 3-5 part Rhizoma Chuanxiong, 6-10 part Fructus Jujubae, 6-10 part Radix Glycyrrhizae.
The preparation method that is used for the medicine of above-mentioned treatment erythroderma desquamativum, comprises the steps:
(1) by proportioning, take each component, standby;
(2) Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae, Herba Alii fistulosi are decocted with water respectively 3 times, obtain filtrate;
(3) by Radix et Caulis Opuntiae Dillenii peeling, pulverize;
(4) remaining ingredient is ground into powder, then fine powder, filtrate is mixed with Radix et Caulis Opuntiae Dillenii.
In described step (2), Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae, Herba Alii fistulosi are decocted with water respectively 3 times, decoct with water for the first time 1-3h, decoct with water for the second time 2-4h, decoct with water for the third time 1-2h, merging filtrate.
In described step (3), by Radix et Caulis Opuntiae Dillenii peeling, pulverize in flakes or piece.
The present invention is directed to the feature of erythroderma desquamativum, it is main adopting antiinflammatory, sterilization, and health is adjusted to auxiliary mode, according to the principle of tonic, and reasonably combined each component.Wherein, Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae four tastes have strong heat-clearing and toxic substances removing, and the effect of anti-inflammation and sterilization can effectively prevent that patient from further infecting.For the feature of above-mentioned four Chinese medicine, the present invention adopts the mode that decocts 3 times, and it can make the effective ingredient in medicine effectively discharge, and improves therapeutic effect.Meanwhile, in the present invention, be also aided with Rhizoma Zingiberis Recens, Herba Alii fistulosi and Radix et Caulis Opuntiae Dillenii.Rhizoma Zingiberis Recens is warm in nature, pungent, has the effect of heating cold expelling, warming middle-JIAO stomach invigorating, preventing or arresting vomiting parasite killing, is among the peoplely usually used in treating the diseases such as flu, vomiting, dysentery.Rhizoma Zingiberis Recens can play the object of warming middle-JIAO stomach invigorating, can promote patient's appetite, adjusts intestinal digestion balance in patient body.Herba Alii fistulosi nature and flavor, Xin Wen, has a surname's of activating yang numbness, relieving the exterior syndrome by diaphoresis, stomach invigorating is eliminated the phlegm, orectic function.Meanwhile, Herba Alii fistulosi can also relieving the exterior syndrome by diaphoresis, can control anemofrigid cold, rheumatism general pain, paralysis card.In Herba Alii fistulosi, contain protein, fat, sugar, carotene, carbohydrate, inorganic salt, vitamin etc., its medicinal ingredient is Herba Alii fistulosi Bulbus Allii bacteriocidin, volatilization wet goods, has the effect of bactericidal antiphlogistic.And that Radix et Caulis Opuntiae Dillenii itself has is edible, the beauty treatment of medicine and health care, in the present invention, adopt Radix et Caulis Opuntiae Dillenii, Main Basis medicine food is with the principle of mending.Radix et Caulis Opuntiae Dillenii itself has the effect of antiinflammatory, sterilization, and meanwhile, it can provide essential nutritional labeling for patient.Radix et Caulis Opuntiae Dillenii itself has light sweet taste, cool taste, is suitable for eating, therefore, the present invention directly pulverizes Radix et Caulis Opuntiae Dillenii, directly mixes with other components, directly edible, can make patient in the component that effectively absorbs the drug, the mouthfeel having kept, is convenient to taking of patient.
As preferably, the present invention also comprises five of Radix Angelicae Sinensis, Rhizoma Polygonati Odorati, Rhizoma Chuanxiong, Fructus Jujubae, Radix Glycyrrhizae.Radix Angelicae Sinensis, Rhizoma Polygonati Odorati, Rhizoma Chuanxiong, Fructus Jujubae four tastes have nourishing healthy energy, and the effect of invigorating qi and benefiting blood, can promote patient's self recovery, for patient provides necessary nutrition.And the king that Radix Glycyrrhizae is BAICAO has the effect of mediation hundred medicines.
As preferably, preparation method of the present invention is significantly different from the preparation method of other drug.The present invention, according to the feature of different component, decocts, is ground into fine powder, pulverizes in bulk or honor different component respectively.Prepared medicine can directly eat, and has good mouthfeel simultaneously, is convenient to the edible of patient.
The specific embodiment
Disclosed all features in this description, or the step in disclosed all methods or process, except mutually exclusive feature and/or step, all can combine by any way.
Disclosed arbitrary feature in this description, unless narration especially all can be replaced by other equivalences or the alternative features with similar object.That is,, unless narration especially, each feature is an example in a series of equivalences or similar characteristics.
Embodiment 1
Treat a medicine for erythroderma desquamativum, adopt and comprise that the raw material of following weight portion is prepared from: 10g Rhizoma Coptidis, 8g Neoalsomitra integrifoliola (Cogn.) Hucth., 5g Radix Hemsleyae Macrospermae, 5g Rhizoma Belamcandae, 6g Rhizoma Zingiberis Recens, 3g Herba Alii fistulosi, 20g Radix et Caulis Opuntiae Dillenii, the quality sum of above seven medicines is former medicine quality.
Each component is decocted with water 2 times, and the decocting that adds for the first time 5 times of former medicine quality boils 1h, and the decocting that adds for the second time 15 times of former medicine quality boils 2h, collects merging filtrate, is condensed into 20-40ml.In concentrated solution, add adjuvant, make 50 pills, the quality of every pill is 2g.
Embodiment 2
Take respectively 6g Rhizoma Coptidis, 6g Neoalsomitra integrifoliola (Cogn.) Hucth., 4g Radix Hemsleyae Macrospermae, 3g Rhizoma Belamcandae, 7g Rhizoma Zingiberis Recens, 5g Herba Alii fistulosi, 50g Radix et Caulis Opuntiae Dillenii, the quality sum of above seven medicines is former medicine quality.Respectively above-mentioned each component is mixed, decoct with water 3 times.The decocting that adds for the first time 3 times of former medicine quality boils 0.5h, and the decocting that adds for the second time 5 times of former medicine quality boils 1h, and the decocting that adds for the third time 8 times of former medicine quality boils 2h, collects filtrate.In filtrate, add water to 200mL, be divided into 10 parts, every part of 20mL, makes the oral liquid of every of 20mL.
Embodiment 3
Take respectively 8g Rhizoma Coptidis, 8g Neoalsomitra integrifoliola (Cogn.) Hucth., 3g Radix Hemsleyae Macrospermae, 4g Rhizoma Belamcandae, 10g Rhizoma Zingiberis Recens, 5g Herba Alii fistulosi, 200g Radix et Caulis Opuntiae Dillenii, standby.
Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae, Herba Alii fistulosi are decocted with water respectively 3 times, the decocting that adds for the first time 5 times of aforementioned five medicine quality summations boils 1h, the decocting that adds for the second time 8 times of aforementioned five medicine quality summations boils 2h, the decocting that adds for the third time 4 times of aforementioned five medicine quality summations boils 1.5h, collects filtrate.
Rhizoma Zingiberis Recens powder is broken into fine powder, by after Radix et Caulis Opuntiae Dillenii peeling, makes Radix et Caulis Opuntiae Dillenii honor.In Radix et Caulis Opuntiae Dillenii honor, add fine powder, filtrate, mix homogeneously, obtains medicine of the present invention.
Embodiment 4
Take respectively 6g Rhizoma Coptidis, 6g Neoalsomitra integrifoliola (Cogn.) Hucth., 3g Radix Hemsleyae Macrospermae, 5g Rhizoma Belamcandae, 6g Rhizoma Zingiberis Recens, 3g Herba Alii fistulosi, 150g Radix et Caulis Opuntiae Dillenii, 10g Radix Angelicae Sinensis, 3g Rhizoma Polygonati Odorati, 3g Rhizoma Chuanxiong, 9g Fructus Jujubae, 8g Radix Glycyrrhizae, standby.
Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae, Herba Alii fistulosi are decocted with water respectively 3 times, the decocting that adds for the first time 20 times of aforementioned five medicine quality summations boils 3h, the decocting that adds for the second time 25 times of aforementioned five medicine quality summations boils 4h, the decocting that adds for the third time 5 times of aforementioned five medicine quality summations boils 1h, collects filtrate.
Rhizoma Zingiberis Recens, Radix Angelicae Sinensis, Rhizoma Polygonati Odorati, Rhizoma Chuanxiong, Fructus Jujubae, Radix Glycyrrhizae powder are broken into fine powder, by after Radix et Caulis Opuntiae Dillenii peeling, make Radix et Caulis Opuntiae Dillenii honor.In Radix et Caulis Opuntiae Dillenii honor, add fine powder, filtrate, mix homogeneously, obtains medicine of the present invention.
Embodiment 5
Take respectively 9g Rhizoma Coptidis, 6g Neoalsomitra integrifoliola (Cogn.) Hucth., 3g Radix Hemsleyae Macrospermae, 3g Rhizoma Belamcandae, 10g Rhizoma Zingiberis Recens, 5g Herba Alii fistulosi, 80g Radix et Caulis Opuntiae Dillenii, 6g Radix Angelicae Sinensis, 5g Rhizoma Polygonati Odorati, 4g Rhizoma Chuanxiong, 6g Fructus Jujubae, 10g Radix Glycyrrhizae, standby.
Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae, Herba Alii fistulosi are decocted with water respectively 3 times, the decocting that adds for the first time 5 times of aforementioned five medicine quality summations boils 1h, the decocting that adds for the second time 10 times of aforementioned five medicine quality summations boils 2h, and the decocting that adds for the third time 5 times of aforementioned five medicine quality summations boils 1h, collects filtrate.
Rhizoma Zingiberis Recens, Radix Angelicae Sinensis, Rhizoma Polygonati Odorati, Rhizoma Chuanxiong, Fructus Jujubae, Radix Glycyrrhizae powder are broken into fine powder, by after Radix et Caulis Opuntiae Dillenii peeling, make Radix et Caulis Opuntiae Dillenii honor.In Radix et Caulis Opuntiae Dillenii honor, add fine powder, filtrate, mix homogeneously, obtains medicine of the present invention.
Experiment effect
Choose 20 routine erythroderma desquamativumes and treat, wherein 14 female, 6 men, average year 52.3 years old.Wherein, 12 patients take recovery from illness in medicine 5-7 of the present invention days, and 5 patients fully recover in adopting medicine 8-15 of the present invention days, and 2 patients adopt interior recovery from illness in medicine 16-25 of the present invention days, after 1 patient adopts 1 first quarter moon of Drug therapy of the present invention, fully recover.In using process of the present invention, patient body is in good condition, does not occur the reaction of any side effect.Above experimental result explanation, medicine of the present invention has no side effect, and treatment cycle is short, and erythroderma desquamativum is had to good therapeutic effect.
The present invention is not limited to the aforesaid specific embodiment.The present invention expands to any new feature or any new combination disclosing in this manual, and the arbitrary new method disclosing or step or any new combination of process.

Claims (5)

1. treat a medicine for erythroderma desquamativum, adopt and comprise that the raw material of following weight portion is prepared from: 5-10 part Rhizoma Coptidis, 6-8 part Neoalsomitra integrifoliola (Cogn.) Hucth., 3-5 part Radix Hemsleyae Macrospermae, 3-5 part Rhizoma Belamcandae, 5-10 part Rhizoma Zingiberis Recens, 3-5 part Herba Alii fistulosi, 20-200 part Radix et Caulis Opuntiae Dillenii.
2. treat according to claim 1 the medicine of erythroderma desquamativum, it is characterized in that, also comprise the raw material of following weight portion: 5-10 part Radix Angelicae Sinensis, 3-5 part Rhizoma Polygonati Odorati, 3-5 part Rhizoma Chuanxiong, 6-10 part Fructus Jujubae, 6-10 part Radix Glycyrrhizae.
3. according to the preparation method for the treatment of the medicine of erythroderma desquamativum described in claim 1 or 2, it is characterized in that, comprise the steps:
(1) by proportioning, take each component, standby;
(2) Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae, Herba Alii fistulosi are decocted with water respectively 3 times, obtain filtrate;
(3) by Radix et Caulis Opuntiae Dillenii peeling, pulverize;
(4) remaining ingredient is ground into powder, then fine powder, filtrate is mixed with Radix et Caulis Opuntiae Dillenii.
4. treat according to claim 3 the preparation method of the medicine of erythroderma desquamativum, it is characterized in that, in described step (2), Rhizoma Coptidis, Neoalsomitra integrifoliola (Cogn.) Hucth., Radix Hemsleyae Macrospermae, Rhizoma Belamcandae, Herba Alii fistulosi are decocted with water respectively 3 times, decoct with water for the first time 1-3h, decoct with water for the second time 2-4h, decoct with water for the third time 1-2h, merging filtrate.
5. treat according to claim 3 the preparation method of the medicine of erythroderma desquamativum, it is characterized in that, in described step (3), by Radix et Caulis Opuntiae Dillenii peeling, pulverize in flakes or piece.
CN201210323561.6A 2012-09-05 2012-09-05 Drug for treating erythroderma desquamativum and preparation method thereof Pending CN103656542A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210323561.6A CN103656542A (en) 2012-09-05 2012-09-05 Drug for treating erythroderma desquamativum and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210323561.6A CN103656542A (en) 2012-09-05 2012-09-05 Drug for treating erythroderma desquamativum and preparation method thereof

Publications (1)

Publication Number Publication Date
CN103656542A true CN103656542A (en) 2014-03-26

Family

ID=50296100

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210323561.6A Pending CN103656542A (en) 2012-09-05 2012-09-05 Drug for treating erythroderma desquamativum and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103656542A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104367925A (en) * 2014-11-07 2015-02-25 济南高达信息技术有限公司 Traditional Chinese medicine lotion for treating erythroderma and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104367925A (en) * 2014-11-07 2015-02-25 济南高达信息技术有限公司 Traditional Chinese medicine lotion for treating erythroderma and preparation method thereof

Similar Documents

Publication Publication Date Title
CN100339123C (en) Traditional Chinese medicine liquor and preparation method thereof
CN101642540B (en) Chinese patent medicine for tranquilizing and allaying excitement
CN103007215A (en) Chinese medicinal composition for treating edema
CN105664099A (en) Traditional Chinese medicine composition for warming and invigorating kidney yang and preparation method thereof
CN105996024A (en) Nourishing nutrient combination for soup cooking and preparation method of combination
CN102526680A (en) Traditional Chinese medicine composition for treating children autumn diarrhea
CN103169931A (en) Traditional Chinese medicine composition for treating spleen-deficiency abdominal distention
CN108913502A (en) A kind of assembled alcoholic drinks
CN104258359A (en) Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof
CN103656542A (en) Drug for treating erythroderma desquamativum and preparation method thereof
CN103550623B (en) A kind ofly treat the infertile Chinese medicine composition of blood-deficiency type
CN102008623A (en) Traditional Chinese medicine preparation for treating Meniere's syndrome
CN110141656A (en) A kind of Fuke Tiaojing blood-nourishing Chinese medicine composition and preparation method thereof
CN104784476A (en) Traditional Chinese medicine capsule for treating arrhythmia and preparation method
CN103156979B (en) A kind of dispelling speckles and whitening face medicine
CN108310111B (en) Traditional Chinese medicine formula for benefiting qi and nourishing blood, preparation method and application thereof, medicated diet for benefiting qi and nourishing blood and preparation method thereof
CN105920447A (en) Antidepressant health product and preparation method thereof
CN106309939A (en) Medicine for treating headache
CN105194296A (en) Medicine composition for treating heart diseases
CN105596710A (en) Improved capsules capable of tonifying yin and clearing away deficient heat
CN105327316A (en) Medicament for treating anterior hypopituitarism
CN106474359A (en) A kind of medicine treating cerebrovascular
CN104306657B (en) A kind of herbal food therapy composition with conditioning pain in the back function and preparation method thereof
CN105232878B (en) A kind of pharmaceutical composition, its preparation method and pharmaceutical preparation for being used to treat postpartum insufficiency of vital energy and blood
CN104784587A (en) Traditional Chinese medicine composition for treating endocrine disorder type infertility and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140326